PRC
EBS icon

Pearl River Capital’s Emergent Biosolutions EBS Stock Holding History

Pearl River Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,038
Closed -$302K – 459
2021
Q3 		$302K Sell
6,038
-2,893
-32% -$175K 0.08% 319
2021
Q2 		$563K Buy
8,931
+5,019
+128% +$322K 0.16% 203
2021
Q1 		$363K Sell
3,912
-2,207
-36% -$226K 0.12% 250
2020
Q4 		$548K Buy
6,119
+1,254
+26% +$115K 0.2% 173
2020
Q3 		$503K Sell
4,865
-435
-8% -$46.9K 0.21% 166
2020
Q2 		$419K Buy
5,300
+4,163
+366% +$310K 0.21% 160
2020
Q1 		$66K Buy
+1,137
New +$65.5K 0.13% 205
2019
Q2 		– Sell
-658
Closed -$34K – 331
2019
Q1 		$34K Buy
+658
New +$38.8K 0.08% 268

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pearl River Capital's EBS Position: Q4 2021 in Review

Pearl River Capital sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 6,038 shares — an estimated $302K sold.

Pearl River Capital first reported a position in EBS in Q1 2019 and held it in 8 quarters. The position peaked at $563K in Q2 2021. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Pearl River Capital reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • Pearl River Capital sold 6,038 Emergent Biosolutions shares in Q4 2021, an estimated $302K.
  • Pearl River Capital first reported a position in Emergent Biosolutions in Q1 2019 and held it in 8 quarters.
  • Pearl River Capital's Emergent Biosolutions position peaked at $563K in Q2 2021.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Pearl River Capital's 13F filing for Q4 2021, filed 11 Feb 2022.